Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 3/20 | 0.35 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | GAA | P10253 | 2/20 | 0.35 |
| ▸ | KLK7 | P49862 | 1/20 | 0.35 |
| ▸ | KCNH3 | Q9ULD8 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | PKM | P14618 | 2/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2948740 | 1.00 | MAPT (0.39) | MAPTMEN1KMT2ATRPA1LMNA | |
| SCHEMBL812348 | 0.86 | HPGD (0.37) | MAPTMEN1KMT2AHPGDGAA | |
| SCHEMBL809579 | 0.86 | HPGD (0.37) | MAPTMEN1KMT2AHPGDGAA | |
| SCHEMBL812430 | 0.83 | ALDH1A1 (0.40) | MAPTMEN1KMT2AGAANPSR1 | |
| SCHEMBL809526 | 0.83 | ALDH1A1 (0.40) | MAPTMEN1KMT2AGAANPSR1 | |
| SCHEMBL809636 | 0.80 | TRPA1 (0.43) | MAPTMEN1KMT2ATRPA1ALDH1A1 | |
| SCHEMBL812292 | 0.80 | TRPA1 (0.43) | MAPTMEN1KMT2ATRPA1ALDH1A1 | |
| SCHEMBL2437063 | 0.77 | CYP2C19 (0.38) | MAPTMEN1KMT2ALMNAGAA | |
| SCHEMBL2437058 | 0.77 | CYP2C19 (0.38) | MAPTMEN1KMT2ALMNAGAA | |
| SCHEMBL809522 | 0.77 | TDP1 (0.40) | MAPTTRPA1LMNAHPGDGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140228564-A1 | PROCESSES OF ENANTIOSELECTIVELY FORMING AN AMINOXY COMPOUND AND AN 1,2-OXAZINE COMPOUND | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2014-08-14 | — | — | US | disclosed |
| US-20140228564-A1 | PROCESSES OF ENANTIOSELECTIVELY FORMING AN AMINOXY COMPOUND AND AN 1,2-OXAZINE COMPOUND | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2014-08-14 | — | — | US | disclosed |
| US-20140228564-A1 | PROCESSES OF ENANTIOSELECTIVELY FORMING AN AMINOXY COMPOUND AND AN 1,2-OXAZINE COMPOUND | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2014-08-14 | — | — | US | disclosed |
| US-8680335-B2 | Processes of enantioselectively forming an aminoxy compound and an 1,2-oxazine compound | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2014-03-25 | — | — | US | disclosed |
| US-8680335-B2 | Processes of enantioselectively forming an aminoxy compound and an 1,2-oxazine compound | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2014-03-25 | — | — | US | disclosed |
| US-8680335-B2 | Processes of enantioselectively forming an aminoxy compound and an 1,2-oxazine compound | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2014-03-25 | — | — | US | disclosed |
| US-20110224429-A1 | PROCESSES OF ENANTIOSELECTIVELY FORMING AN AMINOXY COMPOUND AND AN 1,2-OXAZINE COMPOUND | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2011-09-15 | — | — | US | disclosed |
| US-20110224429-A1 | PROCESSES OF ENANTIOSELECTIVELY FORMING AN AMINOXY COMPOUND AND AN 1,2-OXAZINE COMPOUND | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2011-09-15 | — | — | US | disclosed |
| US-20110224429-A1 | PROCESSES OF ENANTIOSELECTIVELY FORMING AN AMINOXY COMPOUND AND AN 1,2-OXAZINE COMPOUND | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2011-09-15 | — | — | US | disclosed |
| US-7767860-B2 | Substituted amino alcohols | AUSPEX PHARMACEUTICALS, INC (US) | 2010-08-03 | — | — | US | disclosed |
| US-7767860-B2 | Substituted amino alcohols | AUSPEX PHARMACEUTICALS, INC (US) | 2010-08-03 | — | — | US | disclosed |
| US-7767860-B2 | Substituted amino alcohols | AUSPEX PHARMACEUTICALS, INC (US) | 2010-08-03 | — | — | US | disclosed |
| WO-2009032843-A2 | DEUTERATED ETHAMBUTOLS AND THEIR USE | AUSPEX PHARMACEUTICALS, INC. (US) | 2009-03-12 | — | — | WO | disclosed |
| US-20090068168-A1 | SUBSTITUTED AMINO ALCOHOLS | AUSPEX PHARMACEUTICALS, INC. (US) | 2009-03-12 | — | — | US | disclosed |
| US-20090068168-A1 | SUBSTITUTED AMINO ALCOHOLS | AUSPEX PHARMACEUTICALS, INC. (US) | 2009-03-12 | — | — | US | disclosed |
| US-20090068168-A1 | SUBSTITUTED AMINO ALCOHOLS | AUSPEX PHARMACEUTICALS, INC. (US) | 2009-03-12 | — | — | US | disclosed |
| US-7279601-B2 | Optically active α-aminooxyketone derivatives and process for production thereof | TOKYO UNIVERSITY OF SCIENCE, CENTER FOR SCIENCE AND TECHNOLOGY EXCHANGE (JP) | 2007-10-09 | — | — | US | disclosed |
| US-20060293525-A1 | Optically active alpha-aminooxyketone derivatives and process for production thereof | TOKYO UNIVERSITY OF SCIENCE, CENTER FOR SCIENCE AND TECHNOLOGY EXCHANGE (JP) | 2006-12-28 | — | — | US | disclosed |
| EP-1661885-A1 | OPTICALLY ACTIVE ALPHA-AMINOOXYKETONE DERIVATIVES AND PROCESS FOR PRODUCTION THEREOF | Tokyo University of Science (JP) | 2006-05-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090068168-A1 | SUBSTITUTED AMINO ALCOHOLS | GOT1, AADAT, ADH1A | MAPT 2261/4885MEN1 3270/4885KMT2A 2383/4885 |
| US-20060293525-A1 | Optically active alpha-aminooxyketone derivatives and process for production thereof | ALDH7A1, ASPH, KMO | MAPT 3985/4885MEN1 4298/4885KMT2A 1701/4885 |
| US-20110224429-A1 | PROCESSES OF ENANTIOSELECTIVELY FORMING AN AMINOXY COMPOUND AND AN 1,2-OXAZINE COMPOUND | AHR, CYP2S1, CYP1A1 | MAPT 4747/4885MEN1 4340/4885KMT2A 1871/4885 |
| US-20140228564-A1 | PROCESSES OF ENANTIOSELECTIVELY FORMING AN AMINOXY COMPOUND AND AN 1,2-OXAZINE COMPOUND | AHR, CYP2S1, CYP1A1 | MAPT 4747/4885MEN1 4340/4885KMT2A 1871/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.